Evidence map›Paper›PMID 31538079›Full record

ArticleObstetrics & gynecology science2019

The effect of bee prepolis on primary dysmenorrhea: a randomized clinical trial.

Ensiyeh Jenabi, Bita Fereidooni, Manoochehr Karami, Seyedeh Zahra Masoumi, Mahdi Safari, Salman Khazaei

Open access · diamondAbstract read
In one paragraph

Article in Obstetrics & gynecology science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ensiyeh JenabiAutism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Bita FereidooniMidwife in Social Security Organization, Hamadan, Iran.ORCID https://orcid.org/0000-0002-8436-4076
Manoochehr KaramiResearch Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
Seyedeh Zahra MasoumiMother and Child Care Research Center, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran.
Mahdi SafariMedical Degree in Social Security Organization, Hamadan, Iran.
Salman KhazaeiResearch Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IRSocial Security Office (Thailand) · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePrimary dysmenorrhea typically occurs with no associated pelvic pathology and is common in adolescents and young women. This study evaluated the effect of bee propolis on relief of primary dysmenorrhea.

methodsThe study was performed in 2018 in Hamadan, in western Iran, among female students with primary dysmenorrhea. Participants were randomly divided into two groups, using balanced block randomization, and were administered a placebo or bee propolis capsules for 5 days during two menstruation cycles. The number of participants required was estimated to be 86 in total, with 43 students in each group according to the inclusion criteria. We used the visual analog scale to assess pain severity. The independent

resultsA significant change was found in the mean pain scores during the first (

conclusionOur study showed that the use of bee propolis for two months compared with placebo reduced primary dysmenorrhea during the first and second months after use, with no adverse effects. Therefore, it could be used as an alternative to nonsteroidal anti-inflammatory drugs for relief of primary dysmenorrhea.

Indexed as

AdolescentBee propolisPrimary dysmenorrhea

Identifiers

PMID31538079
PMCPMC6737054
OpenAlexW2965134503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.